Increased binding of polymeric A-IgA to cultured human mesangial cells in IgA nephropathy

Kidney International

Volumn 49, Issue 3, 1996, Pages 839-845

  Lai, Kar Neng ^a   To, Wah Yuen ^a   Li, Philip K T ^a   Leung, Joseph C K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A;

ADULT; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN BLOOD LEVEL; KIDNEY DISEASE; MALE; MESANGIUM CELL; PRIORITY JOURNAL;

ADULT; BIOPOLYMERS; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; GLOMERULAR MESANGIUM; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOGLOBULIN A; MALE; MIDDLE AGED;

EID: 0029864366     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.116     Document Type: Article

References (41)

1. BERGER J: IgA glomerular deposits in renal disease. Transplant Proc 1:939-944, 1969
2. VALENTJIN R, RADL J, HAAJIMAN J, VERMEER B, WEENING J, KAUFFMANN RH, DAHA MR, VAN ES LA: Circulating and mesangial secretory component-binding IgA1 in primary IgA nephropathy. Kidney Int 26:760-766, 1984
3. LOMAX-SMITH JD, ZABROWARNY LA, HOWARTH GS, SEYMOUR AE, WOODROFFE AJ: The immunochemical characterization of mesangial IgA deposits. Am J Pathol 113:359-364, 1983
4. DONINI U, CASANOVA S, ZINI N: The presence of J chain in mesangial immune deposits of IgA nephropathy. Proc Eur Dial Transplant Assoc 19:655-651, 1982
5. MESTECKY J, TOMANA M, CZERKINSKY C, TARKOWSKI S, MATSUDA S, WALDO FB, MOLDOVEANU Z, JULIAN BA, GALLA JH, RUSSELL MW, JACKSON S: IgA-associated renal diseases: Immunochemical studies of IgA1 proteins, circulating immune complexes, and cellular interactions. Semin Nephrol 7:332-335, 1987
6. DELACROIX DL, LIROUX E, VAERMAN JP: High proportion of polymeric IgA in young infant's sera and independence between IgA size and IgA subclass distribution. J Clin Immunol 3:53-58, 1983
7. MONTEIRO RC, HALBWACHS-MECARELLI L, BERGER J, LESAVRE P: Characteristics of eluted IgA in primary IgA nephropathy. Contrib Nephrol 40:107-111, 1984
8. LAI KN, CHAN KW, LAI FM, HO CP, YAN KW: The immunochemical characterization of the light chain in the mesangial IgA deposits in IgA nephropathy. Am J Clin Pathol 85:548-551, 1986
9. BENE MC, FAURE GC: Mucosal immunity and IgA nephropathy. Semin Nephrol 7:297-300, 1987
10. ORFILA C, RAKOTOARIVONY J, MANUEL Y, SUC JM: Immunofluorescence characterization of light chains in human nephropathies. Virchows Arch A 412:591-594, 1988
11. JENNETTE C: The immunohistology of IgA nephropathy. Am J Kidney Dis 12:348-352, 1988
12. LAI KN, KN, CHUI SH, LAI FM, LAM C: Predominant synthesis of lambda light chain IgA in IgA nephropathy. Kidney Int 33:584-589, 1988
13. CHUI SH, LAM CWK, LEWIS WP, LAI KN: Light chain ratio of serum IgA1 in IgA nephropathy. J Clin Immunol 11:219-223, 1991
14. CHEN N, NUSBAUM P, HALBWACHS-MECARELLI L, LESAVRE P: Light-chain composition of serum IgA1 and in vitro IgA1 production in IgA nephropathy. Nephrol Dial Transplant 6:846-850, 1991
15. VAN DEN WALL BAKE AWL, DAHA MR, RADL J, HAAUMAN JJ, VAN DER ARK A, VALENTJIN RM, VAN ES LA: The bone marrow as production site of the IgA deposited in the kidneys of patients with IgA nephropathy. Clin Exp Immunol 72:321-325, 1988
16. LAI KN, CHUI SH, LEWIS WHP, POON ASY, LAM CWK: Charge distribution of IgA-lambda in IgA nephropathy. Nephron 66:38-44, 1994
17. LACAVA R, RONDEAU E, OCHI S, DELARUE F, SCHLEUNING WD, SRAER JD: Characterization of a plasminogen activator and its inhibitor in human mesangial cells. Kidney Int 35:806-811, 1989
18. HAGEGE J, DELARUE F, PERALDI MN, SRAER JD, RONDEAU E: Heparin selectively inhibits synthesis of tissue type plasminogen activator and matrix deposition of plasminigen activator inhibitor 1 by human mesangial cells. Lab Invest 71:828-837, 1994
19. STERZEL RB, LOVETT DH, FOELIMER HG, PERFETTO M, BIEMESDERFER D, KASHGARIAN M: Mesangial cell hillocks: Nodular foci of exaggerated growth of cells and matrix in prolonged culture. Am J Pathol 125:130-140, 1986
20. TO WY, LEUNG JCK, LAI KN: Identification and characterization of human serum alpha2-HS glycoprotein as jacalin-bound protein. Biochem Biophys Acta 1249:58-64, 1995
21. CZERKINSKY C, KOOPMAN WJ, JACKSON S, COLLINS JE, CREGO SS, SCHROHENICHER RE, JULIAN BA, GALLA JH, MESTECKY J: Circulating immune complexes and IgA rheumatoid factor in patients with mesangial IgA nephropathies. J Clin Invest 77:1931-1938, 1986
22. HOSODA K, SAKURABAYASHI I, KAWAI T, SUZUKI H, MAEDA M, TSUJI A: Quantitative immunoassay for IgA class circulating immune complexes using solid phase Facb fragment of anti-C3. J Immunol Method 82:243-252, 1985
23. VAN DEN WALL BAKE AWL, DAHA MR, VAN DER ARK A, VALENTIJN R, VAN ES L: Serum levels and in vitro production of IgA subclasses in patients with primary IgA nephropathy. Clin Exp Immunol 75:115-120, 1988
24. 2 using jacalin-agarose chromatography. J Immunol Method 99:101-106, 1987
25. LEBRETON JP, JOISEL F, RAOULT JP, LANNUZEL B, ROGEZ JP, HAMBERT G: Serum concentration of human alpha2 HS glycoprotein during the inflammatory process: Evidence that alpha2 HS glycoprotein is a negative acute-phase reactant. J Clin Invest 64:1118-1129, 1979
26. VAN OSS CJ, GILLMAN CG, BRONSON PM, BORDER JR: Opsonic properties of human serum alpha-2 HS glycoprotein. Immunol Commun 4:329-335, 1974
27. LEWIS JG, ANDRE CM: Enhancement of human monocytic function by alpha2-HS glycoprotein. Immunology 39:317-322, 1980
28. MESTECKY J, TOMANA M, CROWLEY-NOWICK PA, MOLDOVEANU Z, JULIAN BA, JACKSON S: Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy. Contrib Nephrol 104:172-182, 1993
29. TOMINO Y, OHMURO H, TAKAHASHI Y, SUZUKI Y, SAKA S, TASHIRO K, SHIRATO I, KOIDE H: Binding capacity of serum IgA to jacalin in patients with IgA nephropathy using jacalin-coated microplates. Nephron 70:329-333, 1995
30. MESTECKY J, ON H, TOMANA H: Alterations in the IgA carbohydrate chains influence the cellular distribution of IgA. Contrib Nephrol 111:66-72, 1995
31. HIKI Y, HORII A, IWASE H, HOTTA K, KOBAYASHI Y: O-linked oligosaccharide on IgA1 hinge region in IgA nephropathy. Contrib Nephrol 111:73-84, 1995
32. ALLEN AC, HARPER SJ, LAYWARD L, FEEHALLY J: Increased O-linked N-acetyl galactosamine in the hinge region of IgA1 in IgA nephropathy. Contrib Nephrol 111:85-92, 1995
33. VAN DEN DOBBELSTEEN MEA, VAN DER WOUDE FJ, SCHROEIJERS WEM, VAN DEN WALL BAKE AWL, VAN ES LA, DAHA MR: Binding of dimeric and polymeric IgA to rat renal mesangial cells enhances the release of interleukin 6. Kidney Int 46:512-519, 1994
34. MESTECKY J, MCGHEE JR: Immunoglobulin A: Molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv Immunol 40:153-245, 1987
35. ISAACS KL, MILLER F: Role of antigen size and charge in immune complex glomerulonephritis - Active induction of disease with dextran and its derivatives. Lab Invest 47:198-205, 1982
36. GALLO GR, CAULIN-GLASER T, EMANCIPATOR SN, LAMM ME: Nephritogenicity and differential distribution of glomerular immune complexes related to immunogen charge. Lab Invest 48:353-362, 1983
37. LAI KN, LEUNG JCK: Heat-aggregated IgA prepared from patients with IgA nephropathy increases calcium mobilization and superoxide production of human neutrophils in vitro. Nephron 64:129-135, 1993
38. LAI KN, LEUNG JCK, LI PKT: Heat aggregated IgA prepared from patients with IgA nephropathy increases priming of human neutrophils to produce inositol triphosphate following FMLP stimulation in vitro. Nephron 69:1-8, 1995
39. GOMEZ-GUERRERO C, GONZALEZ E, EGIDO J: Evidence for a specific IgA receptor in rat and human mesangial cells. J Immunol 151:7172-7181, 1993
40. BALL JM, MOLDOVEANU Z, MELSEN LR, KOZLOWSKI PA, JACKSON S, MULLIGAN MJ, MESTECKY JF, COMPANS RW: A polarized human endometrial cell line that binds and transports polymeric IgA. In Vitro Cell Dev Biol Anim 31:196-206, 1995
41. STOCKERT RJ, KRESSNER MS, COLLINS JC, STERNLIEB I, MORELL AG: IgA interaction with the asialoglycoprotein receptor. Proc Natl Acad Sci USA 79:6229-6231, 1982